Evotec AG (EVT)

  6.12
   
  • Change Today:
     -0.19
  • 52 Week High:  9.03
  • 52 Week Low:  5.10
  • Currency: Euro
  • Shares Issued: 150.90m
  • Volume: 146,658
  • Market Cap:  923.22m

Deal with Barclays    Trade now with Barclays Stockbrokers

Evotec AG Overview

Evotec focuses on the research and devolpment of small molecule drugs. The German based company is split into two segments: Services and Pharmaceuticals. The Services division supplies research support services for pharmaceutical and biotechnology companies. The Pharmaceutical divisions researches treatments for diseases of the Central Nervous System.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 14.0%
ROCE 10.0%
Latest F'cast
P/E 25.2
PEG n/a
Pr/Revenue 2.1
Pr/Book 2.0
Latest F'cast
Revenue 18.9%
PBT -21.4%
EPS -56.1%
DPS n/a

Evotec AG Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 127.68 12.49 13.00¢ n/a n/a n/a n/a 0.0%
31-Dec-16 164.51 32.95 20.00¢ 37.2 0.7 +54% n/a 0.0%
31-Dec-17 257.63 26.33 17.00¢ 79.4 n/a -15% n/a 0.0%
31-Dec-18 375.40 72.00 57.00¢ 30.5 0.1 +235% n/a 0.0%
31-Dec-19 446.44 56.56 25.00¢ 92.2 n/a -56% n/a 0.0%

Evotec AG Forecasts

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 778.38 (64.06) (54.14)¢ n/a n/a n/a n/a 0.0%
31-Dec-26 841.71 (19.40) (18.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 935.80 26.80 9.50¢ 66.4 n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Evotec AG Market Data

Currency Euro
Share Price   6.12
Change Today   -0.19
% Change -3.01 %
52 Week High  9.03
52 Week Low  5.10
Volume 146,658
Shares Issued 150.90m
Market Cap  923.22m

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page